Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.
Crit Care Med
; 24(5): 733-42, 1996 May.
Article
em En
| MEDLINE
| ID: mdl-8706447
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Fragmentos Fab das Imunoglobulinas
/
Fator de Necrose Tumoral alfa
/
Sepse
/
Anticorpos Monoclonais
Idioma:
En
Ano de publicação:
1996
Tipo de documento:
Article